Thus, the NC selectivity in CXCR4+ AML cell uptake, and selective elimination by the payload drug, differs from the molecularly targeted small drugs that inhibit proteins involved in maintaining the cancer stem cell phenotype (e.g. Wnt, Hedgehog NFkB). Here, NFKB1 is linked to cancer.